Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
Kuros Biosciences wins 2020 Spine Technology Award from Orthopedics This Week
Kuros announces final result of capital increase – total gross proceeds of CHF 18.6 million raised
Kuros announces results of Rights Offering
Kuros provides an update on the planned Capital Increase
Kuros Biosciences to present new data on the role of osteoimmunology in bone formation at NASS 2020 Annual Meeting
Kuros announces all agenda items were approved at its Extraordinary General Meeting today and launches a discounted rights offering expected to raise up to CHF 15.2 million of gross proceeds